Bictegravir (CAS 1611493-60-7) Antiretroviral Pharmaceutical API

Bictegravir (CAS 1611493-60-7) is a potent integrase strand transfer inhibitor (INSTI) and antiretroviral API, renowned for its targeted action against human immunodeficiency virus (HIV). Its unique molecular structure binds to the HIV integrase enzyme, blocking the integration of viral DNA into host cell genomes— a critical step in viral replication. This high-purity pharmaceutical raw material complies with strict global pharmacopoeial standards, ensuring consistent potency and stability for clinical formulation.

Widely utilized in antiretroviral therapy (ART) drug development, it serves as a core ingredient for once-daily fixed-dose combination medications treating HIV-1 infection. Valued for its high barrier to resistance, favorable safety profile, and minimal drug-drug interactions, it addresses the critical need for effective, convenient HIV treatment options. Choose this trusted antiretroviral API to develop high-quality formulations that suppress viral load and improve the long-term health of HIV-positive patients.